In Quebec, shingles is a common concern, with one in three individuals expected to experience it in their lifetime. As of February 1st, individuals aged 71 and older have been granted free access to the shingles vaccine. However, there is debate over whether the age limit should be lowered, especially since those aged 50 and above are at higher risk for shingles.
Shingles, akin to adult chickenpox, is caused by a virus related to herpes, resulting in painful skin lesions usually on the chest or scalp. Dr. Paul Poirier, a cardiologist, explains that shingles manifests as a tingling or burning sensation followed by red bumps on the skin within 24 to 48 hours.
Annually, Quebec reports 27,000 shingles cases, leading to about 600 hospitalizations and 10 deaths. The disease can be excruciating, causing neuralgia or nerve pain that may persist for months or even years. Severe cases can result in muscle paralysis, hearing loss, or vision impairment.
Individuals aged 50 and above, especially those with underlying health conditions, face a higher risk of shingles and its complications. Vaccination is crucial for prevention, with long-term protection lasting at least a decade. Despite recommendations for broader vaccination, only those aged 71 and older and certain immunocompromised individuals receive free shots in Quebec.
There is growing demand for wider access to the shingles vaccine, particularly among vulnerable populations. Domonique Massie from the Quebec Lung Association criticizes the limited free vaccination eligibility, emphasizing the financial and personal toll of shingles and its symptoms.
While access to the vaccine varies across Canada, with some provinces offering broader coverage, the need for expanded vaccination programs remains a pressing issue to combat the impact of shingles on public health.
Keyphrase: shingles vaccine access
